An ASX share fund has revealed 3 stocks that it holds and loves, which are currently in a price dip.
Aberdeen Standard told clients in a monthly update that Australian stocks are now "in something of a sweet spot".
"The central bank remains committed to a dovish stance, with interest rates expected to remain low until 2024 at least. Meanwhile, commodity prices could rise further as the global growth outlook improves amid the wider rollout of Covid-19 vaccines," the memo read.
"In addition, rosier macro conditions and more upbeat company updates strengthen hopes of a rebound in corporate earnings."
In light of this, it picked out 3 shares in its portfolio that have an optimistic future:
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)
The New Zealand healthcare player has had a rough few weeks. From $32.94 on 27 January, its shares tumbled to as low as $25.46 this month. They're currently trading at $29.90 early Friday afternoon, so is still in a dip.
Aberdeen noted Fisher & Paykel stocks descended because demand for its respiratory hardware was boosted by COVID-19 last year.
"With the global vaccine rollout underway, we expect hospitalisation rates to moderate and resultant hardware sales to reverse from current elevated levels."
But the investment house deemed this to be a temporary dip in earnings.
"We continue to view Fisher and Paykel Healthcare as an attractive holding exposed to longer-term structural growth drivers," the memo read.
"We remain upbeat on the longer-term opportunity to increase higher-margin consumables sales. This will be driven by both a larger number of devices now in circulation, as well as changes."
Mercury NZ Ltd (ASX: MCY)
Another Kiwi business listed on the ASX, the electricity company's stocks are currently in a price dip, having lost almost 19% since 8 January.
But Aberdeen's Ex-20 Australian Fund went as far as selling down its Afterpay Ltd (ASX: APT) shares to get a piece of the action.
"We re-invested these proceeds into Mercury New Zealand, a 100% renewable electricity generator, with the recent share-price pullback offering an attractive entry point."
The 100% green energy business model, according to Aberdeen, is what makes the company compelling.
Wesfarmers Ltd (ASX: WES)
Shares for the conglomerate have come down to $52.48 since they hit a 52-week high of $56.40 back in early February.
And that's caught the eye of Aberdeen's Australian Equities Fund.
It all has to do with Australia's escalating real estate prices.
"Our investment in Wesfarmers reflects our view that the domestic housing recovery will continue to underpin robust earnings at household hardware chain Bunnings over the medium term," Aberdeen told clients.
"Furthermore, we think it will benefit from its recent investment in lithium processing."
